Last $1.35 USD
Change Today +0.03 / 2.27%
Volume 536.3K
AVEO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tuan Ha-Ngoc

Chief Executive Officer, President and Director, AVEO Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 4 different industries.

See Board Relationships
62$1,593,275
As of Fiscal Year 2013

Background*

Mr. Tuan Ha-Ngoc has been the President and Chief Executive Officer of Aveo Pharmaceuticals, Inc. (formerly, GenPath Pharmaceuticals, Inc.) since its inception in 2002. Mr. Ha-Ngoc served as Acting Chief Financial Officer of Aveo Pharmaceuticals, Inc. since December 30, 2013 and its Principal Accounting Officer until July 2014. He Co-founded deNovis Inc. and served as its President and Chief Executive Officer from 1999 to 2002. He served as Corporate Vice President of ...

Read Full Background

Corporate Headquarters*

650 East Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-299-5000
Fax: --

Board Members Memberships*

2002-2006
Former Director
2002-Present
Chief Executive Officer, President and Director
2005-N/A
Former Independent Director and Chairman of Audit Committee

Education*

MBA
INSEAD
MA
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

Salary$567,875
Total Annual Compensation$567,875

Stock Options*

Restricted Stock Awards$636,900
All Other Compensation$12,044
Exercisable Options894,350
Exercisable Options Value$127,500
Unexercisable Options136,146
Total Value of Options$127,500
Total Number of Options1,030,496

Total Compensation*

Total Annual Cash Compensation$579,919
Total Short Term Compensation$567,875
Other Long Term Compensation$648,944
Total Calculated Compensation$1,593,275
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVEO:US $1.35 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.